DNA bacterial load in children with bacteremic pneumococcal community-acquired pneumonia

S Esposito1, A Marchese, A E Tozzi

  • 1Pediatric Clinic 1, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Commenda 9, 20122 Milan, Italy. susanna.esposito@unimi.it

Insights

High pneumococcal DNA load and serotype 19A infection significantly increase the risk of parapneumonic effusion (PPE) in children with community-acquired pneumonia (CAP). Serotypes outside the PCV13 vaccine may also contribute to higher bacterial loads and PPE development.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Pulmonology

Background:

  • Community-acquired pneumonia (CAP) is a common childhood illness.
  • Parapneumonic pleural effusion (PPE), with or without empyema, complicates CAP.
  • Streptococcus pneumoniae is a leading cause of CAP and its complications.

Purpose of the Study:

  • To investigate the association between Streptococcus pneumoniae DNA load and the development of PPE in children.
  • To identify specific pneumococcal serotypes associated with PPE.
  • To explore the role of pneumococcal serotypes not covered by the 13-valent conjugate vaccine (PCV13) in PPE.

Main Methods:

  • Real-time polymerase chain reaction (PCR) was used to quantify pneumococcal DNA load in 72 children with CAP.
  • Bacterial load was correlated with the presence or absence of PPE.
  • Multivariate analysis was employed to assess the significance of bacterial load and serotype in PPE development.

Main Results:

  • A high bacterial load (≥265 DNA copies/mL) was significantly associated with PPE (OR 8.65).
  • Pneumococcal serotype 19A infection showed the highest risk for developing PPE (OR 7.44).
  • Infections with pneumococcal serotypes not included in PCV13 were more frequently associated with PPE, except for serotype 19A.

Conclusions:

  • Elevated pneumococcal DNA load is a significant risk factor for PPE in children with CAP.
  • Serotype 19A is strongly linked to high bacterial loads and PPE development.
  • Pneumococcal serotypes outside the PCV13 vaccine may contribute to increased bacterial load and PPE incidence, warranting further investigation.